ROGER G PHD STOLL
CIK 1191281 · Executive Chairman · last filed 2024-05-28
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Loading insider history…
Disclosed Exposure
$61.13M
Companies
3
Total Filings
47
Lifetime Open-Market Net
$352.8K
Holdings By Company
Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| DCTH | Director | 9,309 | $12.43 | $115.7K | $142.4K | 22 | 2024-05-28 |
| Chelsea Therapeutics International, Ltd. (CHTP) Delisted | Director | 40,000 | — | — | $167.3K | 15 | 2014-01-24 |
| COR | Executive Chairman | 200,000 | $305.06 | $61.01M | $43.1K | 8 | 2009-08-24 |
Recent Filings · Page 3 of 5
47 filingsInsider activity across all companies, newest first. Form 4 rows are post-trade confirmations (buys, sells, grants, exercises). Notice (144) rows are pre-trade notices of intent to sell restricted or control stock under Rule 144 — they may not all execute. Compare adjacent dates to see which notices became actual sales.
| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2012-07-27 | Chelsea Therapeutics International, Ltd. (CHTP) Delisted | Grant (A) | — | $0 | EDGAR |
| 2012-06-19 | DCTH | Grant (A) | +32,680 | $0 | EDGAR |
| 2012-01-27 | Chelsea Therapeutics International, Ltd. (CHTP) Delisted | Mixed | −12,000 | $0 | EDGAR |
| 2011-05-31 | DCTH | Grant (A) | +8,347 | $0 | EDGAR |
| 2011-01-13 | Chelsea Therapeutics International, Ltd. (CHTP) Delisted | Grant (A) | — | $0 | EDGAR |
| 2010-12-17 | DCTH | Grant (A) | +3,022 | $0 | EDGAR |
| 2010-05-10 | DCTH | Grant (A) | — | $0 | EDGAR |
| 2010-01-21 | Chelsea Therapeutics International, Ltd. (CHTP) Delisted | Grant (A) | — | $0 | EDGAR |
| 2009-12-14 | DCTH | Grant (A) | +5,485 | $0 | EDGAR |
| 2009-11-20 | DCTH | Buy (P) | +25,000 | $90.0K | EDGAR |
Form 4 codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.